![Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns | Journal of Nuclear Medicine Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns | Journal of Nuclear Medicine](https://jnm.snmjournals.org/sites/default/files/highwire/jnumed/62/Supplement_3.cover-source.jpg)
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns | Journal of Nuclear Medicine
![Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer - Curium Pharma Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer - Curium Pharma](https://www.curiumpharma.com/wp-content/uploads/2021/11/Sakir-Mutelevic.jpg)
Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer - Curium Pharma
![Ariceum Therapeutics extends Series A by $25m to propel radiopharmaceuticals through clinical trials Ariceum Therapeutics extends Series A by $25m to propel radiopharmaceuticals through clinical trials](https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/headlines/bio-developments/ariceum-therapeutics-extends-series-a-by-25m-to-propel-radiopharmaceuticals-through-clinical-trials/16347424-1-eng-GB/Ariceum-Therapeutics-extends-Series-A-by-25m-to-propel-radiopharmaceuticals-through-clinical-trials.jpg)
Ariceum Therapeutics extends Series A by $25m to propel radiopharmaceuticals through clinical trials
![The €80 million Series B establishes a European leader in Radiopharmaceuticals - Facts & Factors - Market Research Blog The €80 million Series B establishes a European leader in Radiopharmaceuticals - Facts & Factors - Market Research Blog](https://www.fnfresearch.com/blog/wp-content/uploads/2022/04/radiopharmaceutical-drug-development.jpeg)
The €80 million Series B establishes a European leader in Radiopharmaceuticals - Facts & Factors - Market Research Blog
![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig3_HTML.png)
Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery
![Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery Radiopharmaceutical therapy in cancer: clinical advances and challenges | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-020-0073-9/MediaObjects/41573_2020_73_Fig1_HTML.png)